Microarray Analysis Market: By Product& Services (Consumables, Software and Services, Others), By Type (DNA Microarrays, Protein Microarrays), By Application (Drug discovery, Disease Diagnostic, Research Applications), By End User (Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories), and by Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2030

Microarray Analysis Market Forecast

The Microarray Analysis Market is expected to reach USD 4,940.22 million by 2030 at 8.20% CAGR during the forecast period 2022-2030.

Microarray Analysis Market Overview:

Microarray is a powerful approach used to analyze gene expression in various experimental purposes. Numerous microarray platforms are available for testing. The development of microarrays had improved the results of genetic testing.

The global microarrays analysis market is majorly driven by the high prevalence of cancer and the rising need for research in pharmaceutical industries. The increasing prevalence of different chronic diseases, use of this technique to diagnose infectious diseases, development in the field of genetics, and increasing healthcare expenditure have provided a push to themarket.However, the high cost of tests and the need for high-tech instruments may restrain the growth of microarray analysis market.

COVID-19 Analysis Of Microarray Analysis Market 

The COVID-19 pandemic has disrupted the global supply chain and interrupted the entire value chain of the global microarray analysis market, from raw material procurement to manufacturing, packaging, and distribution.With several manufacturers having the required raw material and end-product stock, the impact does not seem high for a short duration. However, if the pandemic prolongs and trade restrictions are extended, the impact is expected to rise.COVID-19 can affect the global economy in three main ways:directly impacting production and demand, causing supply chain and market disruption, and having a financial impact on businesses and financial markets.The pandemic has resulted in new product approval through Emergency Use Authorization (EUA) status. On 9th June 2020, the US FDA issued a EUA for the Illumina COVIDSeq Test, a high-throughput, sequencing-based, in vitro diagnostic workflow enabling the detection of SARS-CoV-2.The growing applications of microarray technology and the increasing patient population suffering from various diseases are anticipated to increase the demand for testing and research.

Microarray Analysis Market Dynamics:

Drivers:

• Growing application area of microarrays:

Best known for their use in screening, DNA microarrays have also advanced the pace of disease research. Theydetect differences between healthy control tissue and cancerous tissue. A large number of applications of microarrays are anticipated to increase the need for products used in the analysis. cDNA microarrays can only be used for gene expression analysis, but oligonucleotide microarrays can be utilised for both mutation-genotyping and gene expression analysis.

• Increasing incidence of cancer:


• Funding for genomic and proteomic research:

• Presence of substitutes and lack of skilled professionals:

The availability of substitutes and the presence of alternate mediums for the analysis hinder the growth of the microarray analysis market. For example, RNA-sequencing allows for full sequencing of the whole transcriptome, while microarray analysis only profiles predefined transcripts/genes through hybridization. Moreover, the lack of skilled professionals and the need for standardization of databases are some of the factors hampering the growth of the market.

Opportunities:

• New product launch in developing markets:

The increasing development in the diagnosis and treatment option has led to the development of products that can help patients for a large application. A book published in 2018, Genomic Medicine in Emerging Economies,demonstrates how advances in medical science have already transformed health systems and led to improved patient care in Indonesian, Chilean, Malaysian, Argentinian, Chinese, Sri Lankan, and Colombian populations. With changingexternal business environment due to increasing demand from researchers and clinicians, major players, such as Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina, and Bio-Rad Laboratories, Inc., have launched new products in recent years.

Value Chain Analysis

The global microarray analysis market is growing steadily and is expected to continue growing at the same rate in the near future. This is due to the growing contribution of existing players to make the product more effective. The supply chain analysis for the microarray analysis market comprises four major components, which start with the research and product development (R&D) followed by manufacturing of the products, distribution & sales, and ends with post-sales monitoring.

Global Microarray Analysis Market Share (%),By Product & Services, 2019Source: MRFR Analysis

Microarray Analysis Market Segment Overview:

By Product & Services

• Consumables

Consumables are used for the microarrays are slides, functionalized glass slides, plastic slides, and functionalized cover slides. These consumables find applications in the microarray techniques and are used for the scanning of the genes. A rise in the number of diagnostic laboratories and research institutes has led to a rise in the demand for consumables. Moreover, the rise in the number of DNA methylation and mRNA studies has led to the rise in the adoption of consumables for microarrays

• Software and Services

Microarray services and software are used for the analysis and identification of genomes. The data is analyzed using the software. The rise in the experiments has increased the adoption of tools and services which contributes for the demand for the software and services. Rising demand for the determination and characterization of the human proteins has led to the adoption of the services and software for microarrays, thereby contributing to microarray analysis market growth.

• Instruments

Several tools are used for the analysis of microarrays, including microarray ovens, that find applications for the analysis of the genes and are one of the major factors boosting the demand for the instruments. Chips, plates, and forceps are some of the instruments that find applications in microarrays. The wide availability of chips and plates and rise in the adoption of new technologies contributes to the high demand for instruments

By Type

• DNA Microarrays

DNA microarrays are used to detect mutations in a specific gene’s DNA structure and can be used to diagnose diseases and genetic disorders. Rising prevalence of cancer is one of the factors, that contributes to the demand for DNA microarrays. According to the World Health Organization in 2018, around 1.8 million people are expected to be diagnosed with cancer. Additionally, in 2020, according to the American Cancer Society 45% of new cases were diagnosed in the US

• Protein Microarrays

Protein chips or protein microarrays are used for the determination and analysis of the interactions of the proteins. Increased spending on research and development activities is also one of the factors, likely to contribute to the rising demand for protein microarrays. According to the National Science Foundation, the funding for research & development increased from USD 61 billion in 2017 to 63 billion in 2018

• Others

Some of the other types of microarrays consist of MM chips, tissue microarrays, antibody microarrays, carbohydrate microarrays, and peptide microarrays.

By Application

• Drug Discovery

Drug discovery is defined as a technique, which finds its application in the determination and the analysis of drugs. There are four stages in the drug discovery process: phase I, phase II, phase III, and phase IV. According to the American Society of Council and Health, in 2018, the 13.8% of the molecules, which are tested are successful. Rising research & development has led to the rise in the number of clinical trials, which are some of the factors contributing to the microarray analysis market growth

• Disease Diagnostics

Microarrays are widely used in the diagnosis and analysis of molecules. The rise in the prevalence of chronic diseases has led to the rise in the demand for disease diagnostic. Cardiovascular diseases (CVDs) are the number 1 cause of deaths globally, taking an estimated 17.9 million lives each year

• Research Applications

Research applications are used for the analysis and determination and diagnosis of diseases. DNA molecules are diagnosed using microarrays and help in the determination of the progress of the diseases. The accuracy of the detection of the mutations is high using the microarrays and is one of the major factors contributing to the demand for microarrays

• Others

Microarrays also find applications in the determination of genes, pathogens, genomics, proteomics, and toxicology research. They are also used in the food industry for the analysis and determination of the pathogens. The RNA of the microbes is studied in the food industry

By Application

• 
  
  Research & Academic Institutes
  
  

• Pharmaceutical & Biotechnology Companies

Pharmaceutical and biotechnology companies are the organizations that develop and manufacture drugs. Several research programs are conducted by the pharmaceutical and biotechnology companies for the diagnosis and development of new drugs. Medical products are manufactured, after the research studies are completed by the biotechnology and pharmaceutical companies

• Diagnostic Laboratories

Diagnostic laboratories are used for the analysis and the detection of diseases. The rise in the prevalence of diseases has led to the adoption of microarray analysis. Several diagnostic laboratories relate to hospitals, which contributes to the demand for diagnostic laboratories

• Others

Microarrays are also used in forensic centers, hospitals, contract research organizations, and DNA & gene chip manufacturers. Several drugs are manufactured by contract research organizations. Microarrays are widely used for the analysis and determination of the mutation of the molecules. The molecules are screened using the microarray techniques and are widely used in several contract research organizations

Global Microarray Analysis Market Share (%), by Region, 2019Source: MRFR Analysis

Microarray Analysis Market Regional Analysis

The global microarray analysismarket, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

• Americas

In 2019, the Americas accounted for the largest market share of 40.98% and were estimated to dominate the global microarray analysis market throughout the forecast period. This largest market share can be attributed to the increasing adoption of new technologies and the presence of major players in the region. The Americas is further categorized into North America and Latin America.

The North America market comprises the US and Canada. The increasing prevalence of cancer and the rise in funding for research and development in this region are key factors supporting the growth of the microarray analysis market in North America. For instance, in 2019, the National Institute of Cancer received funding of around USD 42.1 for cancer research. Microarrays are used for the identification of cancer cells and the determination of the genetic structure of the cell. Moreover, the rise in the demand for new drugs has led to increased funding for proteomics and genomics, thereby contributing to microarray analysis market growth.

• Europe

Europe holds a healthy share in the global microarray analysis market and is the second-largest market after the Americas, owing to the highly developed healthcare industry, prominent research & development infrastructure, and accessibility of products. The European microarray analysis market is segmented into Western Europe and Eastern Europe. Western Europe is further segmented into Germany, France, the UK, Spain, Italy, and the Rest of Western Europe. The microarray market in Europe is expected to propel owing to factors such as the prevalence of cancer and several chronic diseases in the region.

• Asia-Pacific

The microarray analysis market in Asia-Pacific is segmented into China, Japan, India, the Republic of Korea, Australia, and the Rest of Asia-Pacific. This regional market is anticipated to be the second fastest-growing globally due to the growing geriatric population and increasing prevalence of chronic diseases and cancer, which led to the adoption of precision medicines.

• Middle East & Africa

The Middle East & Africa microarray analysis market is expected to depict the least share in the market throughout the forecast period owing to factors such as underdeveloped research, lack of awareness among consumers, and low disposable income facilities in African countries. The rising prevalence of cancer in the Middle East is one of the major factors for the adoption of microarrays for research and development. However, the global microarray analysis market in Africa is expected to grow slowly owing to underdeveloped healthcare facilities and a lack of research facilities in Africa.

Competitive Landscape

The global microarray analysis market is characterized by the presence of many global, regional, and local vendors catering to the demand for microarray. The availability of innovative products is increasing the lucrativeness of the global microarray analysis market. The key players have adopted the strategy of signing contracts and agreements for expanded regional reach and optimized operational costs. The market is highly competitive, with players competing and partnering to gain a substantial market share. The global microarray analysis market is highly fragmented with rising competition, product launches, collaborative partnerships, and other strategic decisions that are undertaken to achieve operational efficiency.

• Agilent Technologies (US)


• Bio-Rad Laboratories (US)


• Illumina (US)


• Thermo Fisher Scientific (US)


• Microarrays, Inc. (US)


• PerkinElmer, Inc. (US)


• Merck KGaA (Germany)


• GE Healthcare (US)


• Danaher Corporation (US)


• Arrayit Corporation (US)

Recent Developments

Some of the key strategies followed by players operating in the microarray analysis market were product launches, collaborative partnerships, acquisitions, and expansions.

• In June 2020, Thermo Fisher Scientific launched the Axiom Human Genotyping SARS-CoV-2 Research Array, which will help epidemiologists to study the SARS-CoV-2 infectious disease.


• In April 2020,Bio-Rad acquired Celsee, Inc. helped improve the company's capabilities in single-cell isolation, detection, and analysis.


• In August 2019, Agilent Technologies, Inc. acquired Lionheart Technologies LLC ("BioTek"), a recognized global leader in the design, manufacturing, and distribution of innovative life science instrumentation. Its comprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators, and stackers.

Microarray Analysis Market Report Overview:

The study covers the existing short-term and long-term market effects, helping decision-makers to draught short-term and long-term plans for businesses by region. The report covers major regions in the Americas, Europe, Asia-Pacific, and Middle East & Africa. The report analyzes market drivers, restraints, opportunities, challenges, Porter's five forces, value chain, and impact of COVID-19 on the microarray analysis market. Microarray Analysis Market Scope of the Report & Segmentation

The scope of the global microarray analysis market study includes the market size analysis and a detailed analysis of the manufacturer's products and strategies. The market has been segmented based on product & service, type, application, end user, and region.

Global Microarray Analysis Market, By Product &Services

• Consumables


• Software and Services


• Instruments

Global Microarray Analysis Market, By Type

• DNA Microarrays


• Protein Microarrays


• Others

Global Microarray Analysis Market, By Application

• Drug Discovery


• Disease Diagnostics


• Research Applications


• Others

Global Microarray Analysis Market, By End User

• Research & Academic Institutes


• Pharmaceutical & Biotechnology Companies


• Diagnostic Laboratories


• Others

Global Microarray Analysis Market, By Region

• 
  Americas
  
  
  
  • 
    North America
    
    
    
    • US
    
    
    • Canada
    
    
    
    
  
  
  • 
    Latin America
    
    
    
    • Brazil
    
    
    • Mexico
    
    
    • Rest of Latin America
    
    
    
    
  
  
  
  


• 
  Europe
  
  
  
  • 
    Western Europe
    
    
    
    • Germany
    
    
    • France
    
    
    • UK
    
    
    • Italy
    
    
    • Spain
    
    
    • Rest of Europe
    
    
    
    
  
  
  • Eastern Europe
  
  
  
  


• 
  Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• 
  Middle East & Africa
  
  
  
  • Middle East
  
  
  • Africa